Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Other Issues:
Previous Next
  [Index by Author]
 
Contents: Volume 20, Issue 1
January 1, 2002
 

Down EDITORIALS
Down ORIGINAL REPORTS
  Down Breast Cancer
  Down Supportive Care and Quality of Life
  Down Phase I and Clinical Pharmacology
  Down Melanoma
  Down AIDS Related Cancer
  Down Gastrointestinal Cancer
  Down Gynecologic Cancer
  Down Sarcomas
  Down Hematologic Malignancies
  Down Pediatric Oncology
  Down Lung Cancer
  Down Head and Neck Cancer
  Down Genitourinary Cancer
  Down Cost Effectiveness
Down BIOLOGY OF NEOPLASIA
Down REVIEW ARTICLES
Down DIAGNOSIS IN ONCOLOGY
Down ART OF ONCOLOGY
Down SPECIAL DEPARTMENTS
  Down CORRESPONDENCE

Find articles in this issue containing these words:
[Search ALL Issues]


To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

 
EDITORIALS Back
Chemoprevention of Breast Cancer: A Model for Change
V. Craig Jordan and Monica Morrow
JCO Jan 1 2002: 1–3. [Full Text] [PDF]  
Asking the Obvious Questions Regarding Patient Burden
Jeff Sloan
JCO Jan 1 2002: 4–6. [Full Text] [PDF]  
Irinotecan Dosing: Does the CPT in CPT-11 Stand for "Can’t Predict Toxicity"?
Mark J. Ratain
JCO Jan 1 2002: 7–8. [Full Text] [PDF]  
 
ORIGINAL REPORTS Back

Breast Cancer Back

Outcomes of Tamoxifen Chemoprevention for Breast Cancer in Very High-Risk Women: A Cost-Effectiveness Analysis
  Dawn Hershman, Vijaya Sundararajan, Judith S. Jacobson, Daniel F. Heitjan, Alfred I. Neugut, and Victor R. Grann
  JCO Jan 1 2002: 9–16. [Abstract] [Full Text] [PDF]  
Predictors of Local-Regional Recurrence After Neoadjuvant Chemotherapy and Mastectomy Without Radiation
  Thomas A. Buchholz, Susan L. Tucker, Lawrence Masullo, Henry M. Kuerer, Jessica Erwin, Jessica Salas, Debbie Frye, Eric A. Strom, Marsha D. McNeese, George Perkins, Angela Katz, S. Eva Singletary, Kelly K. Hunt, Aman U. Buzdar, and Gabriel N. Hortobagyi
  JCO Jan 1 2002: 17–23. [Abstract] [Full Text] [PDF]  
Randomized, Controlled, Dose-Range Study of Ro 25-8315 Given Before and After a High-Dose Combination Chemotherapy Regimen in Patients With Metastatic or Recurrent Breast Cancer Patients
  P. Viens, C. Chabannon, P. Pouillard, M. Janvier, W. Brugger, J. Y. Blay, F. Oberling, R. Capdeville, C. Newman, V. Méresse, Z. X. Xu, E. Platzer, P. Van der Auwera, and D. Maraninchi
  JCO Jan 1 2002: 24–36. [Abstract] [Full Text] [PDF]  
Phase II Trial of Biweekly Administration of Vinorelbine and Gemcitabine in Pretreated Advanced Breast Cancer
  George P. Stathopoulos, Sotiris K. Rigatos, Nikos Pergantas, Dimitris Tsavdarides, Ilias Athanasiadis, Nikos A. Malamos, and John G. Stathopoulos
  JCO Jan 1 2002: 37–41. [Abstract] [Full Text] [PDF]  
Fasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort Study
  Pamela J. Goodwin, Marguerite Ennis, Kathleen I. Pritchard, Maureen E. Trudeau, Jarley Koo, Yolanda Madarnas, Warren Hartwick, Barry Hoffman, and Nicky Hood
  JCO Jan 1 2002: 42–51. [Abstract] [Full Text] [PDF]  
Survey of Modalities of Toxicity Assessment and Reporting in Noncomparative Prospective Studies of Chemotherapy in Breast Cancer
  Francesco Perrone, Ermelinda De Maio, Paolo Maione, Massimo Di Maio, Alessandro Ottaiano, Matilde Pensabene, Giuseppe Di Lorenzo, Alessandra Vernaglia Lombardi, and Ciro Gallo
  JCO Jan 1 2002: 52–57. [Abstract] [Full Text] [PDF]  
Reinfusion of Autologous Lymphocytes With Granulocyte-Macrophage Colony-Stimulating Factor Induces Rapid Recovery of CD4+ and CD8+ T Cells After High-Dose Chemotherapy for Metastatic Breast Cancer
  G. C. de Gast, F. A. Vyth-Dreese, W. Nooijen, C. J.C. van den Bogaard, J. Sein, M. M.J. Holtkamp, G. A.M. Linthorst, J. W. Baars, J. H. Schornagel, and S. Rodenhuis
  JCO Jan 1 2002: 58–64. [Abstract] [Full Text] [PDF]  

Supportive Care and Quality of Life Back

Patients’ Estimation of Overall Treatment Burden: Why Not Ask the Obvious?
  J. Bernhard, R. Maibach, B. Thürlimann, C. Sessa, and M. S. Aapro
  JCO Jan 1 2002: 65–72. [Abstract] [Full Text] [PDF]  
Quality of Life in Long-Term Survivors of Testicular Cancer: A Population-Based Case-Control Study
  F. Joly, J. F. Héron, L. Kalusinski, P. Bottet, D. Brune, N. Allouache, J. Macé-Lesec’h, J. E. Couëtte, J. Pény, and M. Henry-Amar
  JCO Jan 1 2002: 73–80. [Abstract] [Full Text] [PDF]  
Safety and Efficacy of Alteplase for Restoring Function in Occluded Central Venous Catheters: Results of the Cardiovascular Thrombolytic to Open Occluded Lines Trial
  Steven R. Deitcher, Mark R. Fesen, Paul M. Kiproff, Patricia A. Hill, Xin Li, Edward R. McCluskey, and Charles P. Semba
  JCO Jan 1 2002: 317–324. [Abstract] [Full Text] [PDF]  

Phase I and Clinical Pharmacology Back

Impact of Body-Size Measures on Irinotecan Clearance: Alternative Dosing Recommendations
  Ron H.J. Mathijssen, Jaap Verweij, Maja J.A. de Jonge, Kees Nooter, Gerrit Stoter, and Alex Sparreboom
  JCO Jan 1 2002: 81–87. [Abstract] [Full Text] [PDF]  
Phase I Study of Combination Topotecan and Carboplatin in Pediatric Solid Tumors
  Uma H. Athale, Clinton Stewart, John F. Kuttesch, Albert Moghrabi, William Meyer, Charles Pratt, Amar Gajjar, and Richard L. Heideman
  JCO Jan 1 2002: 88–95. [Abstract] [Full Text] [PDF]  
Troxacitabine, an L-Stereoisomeric Nucleoside Analog, on a Five-Times-Daily Schedule: A Phase I and Pharmacokinetic Study in Patients With Advanced Solid Malignancies
  Johann S. de Bono, Joseph Stephenson, Jr, Sharyn D. Baker, Manuel Hidalgo, Amita Patnaik, Lisa A. Hammond, Geoffrey Weiss, Andrew Goetz, Lillian Siu, Cecelia Simmons, Jacques Jolivet, and Eric K. Rowinsky
  JCO Jan 1 2002: 96–109. [Abstract] [Full Text] [PDF]  
Pharmacodynamic Studies of the Epidermal Growth Factor Receptor Inhibitor ZD1839 in Skin From Cancer Patients: Histopathologic and Molecular Consequences of Receptor Inhibition
  Joan Albanell, Federico Rojo, Steve Averbuch, Andrea Feyereislova, Jose Manuel Mascaro, Roy Herbst, Patricia LoRusso, Danny Rischin, Silvia Sauleda, Julia Gee, Robert I. Nicholson, and Jose Baselga
  JCO Jan 1 2002: 110–124. [Abstract] [Full Text] [PDF]  

Melanoma Back

Results From a Randomized Phase III Study Comparing Combined Treatment With Histamine Dihydrochloride Plus Interleukin-2 Versus Interleukin-2 Alone in Patients With Metastatic Melanoma
  Sanjiv S. Agarwala, John Glaspy, Steven J. O’Day, Malcolm Mitchell, John Gutheil, Eric Whitman, Rene Gonzalez, Evan Hersh, Lynn Feun, Robert Belt, Frank Meyskens, Kristoffer Hellstrand, Diana Wood, John M. Kirkwood, Kurt R. Gehlsen, and Peter Naredi
  JCO Jan 1 2002: 125–133. [Abstract] [Full Text] [PDF]  
Melanoma Information on the Internet: Often Incomplete—A Public Health Opportunity?
  Christopher K. Bichakjian, Jennifer L. Schwartz, Timothy S. Wang, Janette M. Hall, Timothy M. Johnson, and J. Sybil Biermann
  JCO Jan 1 2002: 134–141. [Abstract] [Full Text] [PDF]  
Phase I Study of the Intravenous Administration of Attenuated Salmonella typhimurium to Patients With Metastatic Melanoma
  John F. Toso, Vee J. Gill, Patrick Hwu, Francesco M. Marincola, Nicholas P. Restifo, Douglas J. Schwartzentruber, Richard M. Sherry, Suzanne L. Topalian, James C. Yang, Frida Stock, Linda J. Freezer, Kathleen E. Morton, Claudia Seipp, Leah Haworth, Sharon Mavroukakis, Donald White, Susan MacDonald, John Mao, Mario Sznol, and Steven A. Rosenberg
  JCO Jan 1 2002: 142–152. [Abstract] [Full Text] [PDF]  

AIDS Related Cancer Back

Matrix Metalloproteinase Inhibitor COL-3 in the Treatment of AIDS-Related Kaposi’s Sarcoma: A Phase I AIDS Malignancy Consortium Study
  Mary Cianfrocca, Timothy P. Cooley, Jeannette Y. Lee, Michelle A. Rudek, David T. Scadden, Lee Ratner, James M. Pluda, William D. Figg, Susan E. Krown, and Bruce J. Dezube
  JCO Jan 1 2002: 153–159. [Abstract] [Full Text] [PDF]  

Gastrointestinal Cancer Back

Phase II Study of Oral Capecitabine in Patients With Advanced or Metastatic Pancreatic Cancer
  Thomas H. Cartwright, Allen Cohn, Jerry A. Varkey, Yin-Miao Chen, Ted P. Szatrowski, John V. Cox, and Joseph J. Schulz
  JCO Jan 1 2002: 160–164. [Abstract] [Full Text] [PDF]  
Randomized Multicenter Phase II Trial of Oxaliplatin Plus Irinotecan Versus Raltitrexed as First-Line Treatment in Advanced Colorectal Cancer
  Werner Scheithauer, Gabriela V. Kornek, Markus Raderer, Herbert Ulrich-Pur, Wolfgang Fiebiger, Claudia Gedlicka, Birgit Schüll, Stefan Brugger, Bruno Schneeweiss, Fritz Lang, Alfred Lenauer, and Dieter Depisch
  JCO Jan 1 2002: 165–172. [Abstract] [Full Text] [PDF]  

Gynecologic Cancer Back

Variations in the Use of Chemotherapy for Elderly Patients With Advanced Ovarian Cancer: A Population-Based Study
  Vijaya Sundararajan, Dawn Hershman, Victor R. Grann, Judith S. Jacobson, and Alfred I. Neugut
  JCO Jan 1 2002: 173–178. [Abstract] [Full Text] [PDF]  
Neoadjuvant Chemotherapy and Radical Surgery Versus Exclusive Radiotherapy in Locally Advanced Squamous Cell Cervical Cancer: Results From the Italian Multicenter Randomized Study
  Pierluigi Benedetti-Panici, Stefano Greggi, Alessandro Colombo, Mariangela Amoroso, Daniela Smaniotto, Diana Giannarelli, Gianni Amunni, Francesco Raspagliesi, Paolo Zola, Costantino Mangioni, and Fabio Landoni
  JCO Jan 1 2002: 179–188. [Abstract] [Full Text] [PDF]  

Sarcomas Back

High-Dose Samarium-153 Ethylene Diamine Tetramethylene Phosphonate: Low Toxicity of Skeletal Irradiation in Patients With Osteosarcoma and Bone Metastases
  Peter M. Anderson, Gregory A. Wiseman, Angela Dispenzieri, Carola A.S. Arndt, Lynn C. Hartmann, William A. Smithson, Brian P. Mullan, and Oyvind S. Bruland
  JCO Jan 1 2002: 189–196. [Abstract] [Full Text] [PDF]  

Hematologic Malignancies Back

Brief Chemotherapy and Involved-Region Irradiation for Limited-Stage Diffuse Large-Cell Lymphoma: An 18-Year Experience From the British Columbia Cancer Agency
  Tamara N. Shenkier, Nicholas Voss, Randall Fairey, Randy D. Gascoyne, Paul Hoskins, Richard Klasa, Paul Klimo, Susan E. O’Reilly, Simon Sutcliffe, and Joseph M. Connors
  JCO Jan 1 2002: 197–204. [Abstract] [Full Text] [PDF]  
Campath-1H Treatment of T-Cell Prolymphocytic Leukemia in Patients for Whom at Least One Prior Chemotherapy Regimen Has Failed
  M. J. Keating, B. Cazin, S. Coutré, R. Birhiray, T. Kovacsovics, W. Langer, B. Leber, T. Maughan, K. Rai, G. Tjønnfjord, M. Bekradda, M. Itzhaki, and P. Hérait
  JCO Jan 1 2002: 205–213. [Abstract] [Full Text] [PDF]  
Follow-Up of Complete Cytogenetic Remission in Patients With Chronic Myeloid Leukemia After Cessation of Interferon Alfa
  F. X. Mahon, X. Delbrel, P. Cony-Makhoul, C. Fabères, J. M. Boiron, C. Barthe, C. Bilhou-Nabéra, A. Pigneux, G. Marit, and J. Reiffers
  JCO Jan 1 2002: 214–220. [Abstract] [Full Text] [PDF]  
New Prognostic Score Based on Treatment Outcome of Patients With Relapsed Hodgkin’s Lymphoma Registered in the Database of the German Hodgkin’s Lymphoma Study Group
  Andreas Josting, Jeremy Franklin, Michael May, Peter Koch, Maria K. Beykirch, Juergen Heinz, Christian Rudolph, Volker Diehl, and Andreas Engert
  JCO Jan 1 2002: 221–230. [Abstract] [Full Text] [PDF]  
Importance of Radiotherapy in the Outcome of Patients With Primary CNS Lymphoma: An Analysis of the CHOD/BVAM Regimen Followed by Two Different Radiotherapy Treatments
  E. M. Bessell, A. López-Guillermo, S. Villá, E. Verger, B. Nomdedeu, J. Petit, P. Byrne, E. Montserrat, and F. Graus
  JCO Jan 1 2002: 231–236. [Abstract] [Full Text] [PDF]  

Pediatric Oncology Back

Treatment of Childhood Acute Lymphoblastic Leukemia: Results of Dana-Farber ALL Consortium Protocol 87-01
  Jean Marie LeClerc, Amy L. Billett, Richard D. Gelber, Virginia Dalton, Nancy Tarbell, Jeffrey M. Lipton, Ronald Barr, Luis A. Clavell, Barbara Asselin, Craig Hurwitz, Marshall Schorin, Steven E. Lipshultz, Lieven Declerck, Lewis B. Silverman, Harvey J. Cohen, and Stephen E. Sallan
  JCO Jan 1 2002: 237–246. [Abstract] [Full Text] [PDF]  

Lung Cancer Back

Preoperative Chemotherapy Followed by Surgery Compared With Primary Surgery in Resectable Stage I (Except T1N0), II, and IIIa Non–Small-Cell Lung Cancer
  Alain Depierre, Bernard Milleron, Denis Moro-Sibilot, Sylvie Chevret, Elisabeth Quoix, Bernard Lebeau, Denis Braun, Jean-Luc Breton, Etienne Lemarié, Sylvie Gouva, Nadine Paillot, Jeanne-Marie Bréchot, Henri Janicot, François-Xavier Lebas, Philippe Terrioux, Jean Clavier, Pascal Foucher, Michel Monchâtre, Daniel Coëtmeur, Marie-Claude Level, Pascal Leclerc, François Blanchon, Jean-Michel Rodier, Luc Thiberville, Anne Villeneuve, Virginie Westeel, and Claude Chastang
  JCO Jan 1 2002: 247–253. [Abstract] [Full Text] [PDF]  
Cooperative Role of Telomerase Activity and p16 Expression in the Prognosis of Non–Small-Cell Lung Cancer
  Rosa González-Quevedo, Pilar Iniesta, Alberto Morán, Carmen de Juan, Andrés Sánchez-Pernaute, C. Fernández, Antonio Torres, E. Díaz-Rubio, Jose-Luis Balibrea, and Manuel Benito
  JCO Jan 1 2002: 254–262. [Abstract] [Full Text] [PDF]  
Outcomes and Cost-Effectiveness of Alternative Staging Strategies for Non–Small-Cell Lung Cancer
  Nestor F. Esnaola, Sophia N. Lazarides, Steven J. Mentzer, and Karen M. Kuntz
  JCO Jan 1 2002: 263–273. [Abstract] [Full Text] [PDF]  
Phase II Trial of a Single Weekly Intravenous Dose of Ranpirnase in Patients With Unresectable Malignant Mesothelioma
  Stanislaw M. Mikulski, John J. Costanzi, Nicholas J. Vogelzang, Spence McCachren, Robert N. Taub, Hoo Chun, Abraham Mittelman, Timothy Panella, Carmelo Puccio, Robert Fine, and Kuslima Shogen
  JCO Jan 1 2002: 274–281. [Abstract] [Full Text] [PDF]  

Head and Neck Cancer Back

Increased Risk of Ischemic Stroke After Radiotherapy on the Neck in Patients Younger Than 60 Years
  Lucille D.A. Dorresteijn, Arnoud C. Kappelle, Willem Boogerd, Willem J. Klokman, Alfons J.M. Balm, Ronald B. Keus, Flora E. van Leeuwen, and Harry Bartelink
  JCO Jan 1 2002: 282–288. [Abstract] [Full Text] [PDF]  

Genitourinary Cancer Back

Interferon-Alfa as a Comparative Treatment for Clinical Trials of New Therapies Against Advanced Renal Cell Carcinoma
  Robert J. Motzer, Jennifer Bacik, Barbara A. Murphy, Paul Russo, and Madhu Mazumdar
  JCO Jan 1 2002: 289–296. [Abstract] [Full Text] [PDF]  
Salvage Chemotherapy for Patients With Advanced Pure Seminoma
  Jacqueline Vuky, Satish K. Tickoo, Joel Sheinfeld, Jennifer Bacik, Alison Amsterdam, Madhu Mazumdar, Victor Reuter, Dean F. Bajorin, George J. Bosl, and Robert J. Motzer
  JCO Jan 1 2002: 297–301. [Abstract] [Full Text] [PDF]  
Phase II Trial of Thalidomide for Patients With Advanced Renal Cell Carcinoma
  Robert J. Motzer, William Berg, Michelle Ginsberg, Paul Russo, Jacqueline Vuky, Richard Yu, Jennifer Bacik, and Madhu Mazumdar
  JCO Jan 1 2002: 302–306. [Abstract] [Full Text] [PDF]  

Cost Effectiveness Back

Costs of Treatment for Elderly Women With Early-Stage Breast Cancer in Fee-for-Service Settings
  Joan L. Warren, Martin L. Brown, Michael P. Fay, Nicola Schussler, Arnold L. Potosky, and Gerald F. Riley
  JCO Jan 1 2002: 307–316. [Abstract] [Full Text] [PDF]  
 
BIOLOGY OF NEOPLASIA Back
STI571: A Paradigm of New Agents for Cancer Therapeutics
  Michael J. Mauro, Michael O’Dwyer, Michael C. Heinrich, and Brian J. Druker
  JCO Jan 1 2002: 325–334. [Abstract] [Full Text] [PDF]  
 
REVIEW ARTICLES Back
Palliative Uses of Methylphenidate in Patients With Cancer: A Review
  Mark Rozans, Albert Dreisbach, Juan J.L. Lertora, and Marc J. Kahn
  JCO Jan 1 2002: 335–339. [Abstract] [Full Text] [PDF]  
 
DIAGNOSIS IN ONCOLOGY Back
Extramedullary Sites of Involvement in Hematologic Malignancies: Case 1. Multifocal Intracranial Involvement with Mantle-Cell Lymphoma
Asad Dean, Thomas E. Rogers, Jan Diehl, and Jonathan E. Dowell
JCO Jan 1 2002: 340–342. [Full Text] [PDF]  
Extramedullary Sites of Involvement in Hematologic Malignancies: Case 2. Lymphocyte Morphology in Splenic Marginal Zone Lymphoma
Roger G. Owen
JCO Jan 1 2002: 342–344. [Full Text] [PDF]  
Extramedullary Sites of Involvement in Hematologic Malignancies: Case 3. Hemorrhagic Gastric Plasmacytoma as the Primary Presentation in Multiple Myeloma
C. S. Chim, W. M. Wong, J. Nicholls, L. P. Chung, and R. Liang
JCO Jan 1 2002: 344–347. [Full Text] [PDF]  
 
ART OF ONCOLOGY Back
Opioid Rotation in the Management of Refractory Cancer Pain
Rose Anne Indelicato and Russell K. Portenoy
JCO Jan 1 2002: 348–352. [Full Text] [PDF]  
 
SPECIAL DEPARTMENTS Back

CORRESPONDENCE Back

Replacement of Carboplatin by Oxaliplatin May be One Solution for Patients Treated for Ovarian Carcinoma Who Are Hypersensitive to Carboplatin
M. Gutierrez, P. Pautier, and C. Lhommé
JCO Jan 1 2002: 353. [Full Text] [PDF]  
Human Bone Marrow Myeloma Cells Express RANKL
Orhan Sezer, Ulrike Heider, Christian Jakob, Jan Eucker, Kurt Possinger, and G. David Roodman
JCO Jan 1 2002: 353-a–354. [Full Text] [PDF]  
Tumor Lysis Syndrome After STI571 in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
Eldad J. Dann, Riva Fineman, and Jacob M. Rowe
JCO Jan 1 2002: 354–355. [Full Text] [PDF]  
Radiation Recall Dermatitis From High-Dose Interferon Alfa-2b
Rosalyn Thomas and Baldassarre Stea
JCO Jan 1 2002: 355–357. [Full Text] [PDF]  
Treatment of Intracranial Metastatic Esthesioneuroblastoma
Marc C. Chamberlain
JCO Jan 1 2002: 357–358. [Full Text] [PDF]  


To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.


About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2008 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online